CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Johnston Lloyd P. Chief Operations Officer | Sale | −3,372 | $1.13 | $4K | 265,535 |
| 2023-01-05 | Johnston Lloyd P. Chief Operations Officer | Sale | −20 | $1.11 | $22 | 265,515 |
| 2023-01-05 | Kishimoto Takashi Kei Chief Scientific Officer | Sale | −3,372 | $1.13 | $4K | 364,336 |
| 2023-01-05 | Kishimoto Takashi Kei Chief Scientific Officer | Sale | −20 | $1.11 | $22 | 364,316 |
| 2023-01-05 | TRABER PETER G Chief Medical Officer | Sale | −3,445 | $1.13 | $4K | 446,141 |
| 2023-01-05 | TRABER PETER G Chief Medical Officer | Sale | −20 | $1.11 | $22 | 446,121 |
| 2023-01-04 | Brunn Carsten President and CEO | Sale | −27,549 | $1.13 | $31K | 799,534 |
| 2023-01-04 | Brunn Carsten President and CEO | Sale | −48 | $1.15 | $55 | 799,486 |
| 2023-01-04 | Johnston Lloyd P. Chief Operations Officer | Sale | −6,381 | $1.13 | $7K | 268,918 |
| 2023-01-04 | Johnston Lloyd P. Chief Operations Officer | Sale | −11 | $1.14 | $13 | 268,907 |
| 2023-01-04 | Kishimoto Takashi Kei Chief Scientific Officer | Sale | −6,381 | $1.13 | $7K | 367,719 |
| 2023-01-04 | Kishimoto Takashi Kei Chief Scientific Officer | Sale | −11 | $1.15 | $13 | 367,708 |
| 2023-01-04 | TRABER PETER G Chief Medical Officer | Sale | −8,164 | $1.13 | $9K | 449,601 |
| 2023-01-04 | TRABER PETER G Chief Medical Officer | Sale | −15 | $1.14 | $17 | 449,586 |
| 2023-01-02 | Myers Scott Dunseth Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2023-01-02 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-01-02 | BARABE TIMOTHY C Director | Grant or award · Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2023-01-02 | Brunn Carsten President and CEO | Grant or award | +282,800 | 827,083 | ||
| 2023-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,275,000 | 1,275,000 | ||
| 2023-01-02 | COX CARRIE SMITH Director | Grant or award · Stock Option (Right to Buy) | +107,500 | 107,500 |
Page 19 of 25 · 495 trades